Medical University of Vienna

Arthritis & Rheumatism

New oral treatment option for rheumatoid arthritis

Patients suffering from rheumatoid arthritis are treated for around six months with the standard anti-rheumatic agent methotrexate, to which many patients respond very well. However, if they do not respond and no remission ...

Oncology & Cancer

New hope of a treatment for aggressive T-PLL leukaemia

Until now, there has been no adequate treatment available for the rare and highly aggressive malignant blood disease T-PLL leukaemia. By screening blood samples from patients with haematological diseases, a team of doctors ...

Medications

Stomach-protecting medicines can trigger allergies

Stomach-protecting drugs are widely used. Now, using quantitative prescribing data from Austria, a study conducted by MedUni Vienna in collaboration with the Austrian Social Insurance Institutions, has shown that stomach-protecting ...

Diseases, Conditions, Syndromes

COVID-19: Not all patients develop protective antibodies

A laboratory test developed by a study group from MedUni Vienna can determine whether COVID-19 patients develop protective antibodies after having the disease. Scientists from MedUni Vienna's Institute of Pathophysiology ...

page 3 from 40